Neoplasms – Page 6

Oncology Market in 2025: Innovation, Growth, and Patient-Centric Care

8 months ago talkbio0Tagged Artificial Intelligence, Biosimilars, Clinical Trial Design, Combined, Immunotherapy for cancer, Neoplasms, Personalized cancer care, Precision Medicine, targeted therapies

Cancer immunotherapy, Targeted therapies , Precision medicine, AI in oncology, Combination treatments, Biosimilars, Clinical trial design, Personalized cancer care

Callio Therapeutics Debuts with $187M to Develop Next-Generation Multi-Payload ADCs for Cancer

8 months ago talkbio0Tagged ADCs, Antibody-Drug, Biotechnology, Cancer Therapeutic Procedure, dual-payload technology, HER2-targeted therapy, Immunostimulating conjugate (antigen), multi-payload, Neoplasms

Multi-payload ADCs, antibody-drug conjugates, oncology, HER2-targeted therapy, dual-payload technology, cancer treatment, biotechnology startup

BridgeBio Oncology Therapeutics Goes Public via $450M SPAC Merger

8 months ago talkbio0Tagged Biochemical Pathway, BridgeBio, cancer pipeline, Helix (Snails), inhibitors, K-ras Oncogene, KRAS, Merger, Neoplasms, PI3 K pathway, ras Oncogene, SPAC

BridgeBio, oncology, SPAC merger, Helix Acquisition Corp. II, KRAS inhibitors, cancer pipeline, RAS pathway, PI3K pathway

Eli Lilly Partners with Magnet Biomedicine in $1.25B Molecular Glue Deal

9 months ago talkbio0Tagged Biomedicine, Collaboration, Drug Discovery, Eli, Eli Lilly, Magnet, molecular glue, Neoplasms

Eli Lilly, Magnet Biomedicine, molecular glue, drug discovery, oncology, collaboration

Major Clinical Trial Failures of 2024: Setbacks in Neuroscience and Beyond

9 months ago talkbio0Tagged Alzheimer 's disease, Amyotrophic Lateral Sclerosis, Clinical Trials, Drug Development, Duchenne, Neoplasms, Neuroscience discipline, Schizophrenia

Clinical trials, drug development, neuroscience, ALS, Alzheimer’s disease, schizophrenia, Duchenne muscular dystrophy, oncology

Incyte and Genesis Therapeutics Forge $620M AI-Driven Drug Discovery Partnership

9 months ago talkbio0Tagged Artificial Intelligence, Drug Discovery, Gemini of Coiled Bodies, Immunology, Neoplasms, small molecule therapeutics, strategic collaboration

Artificial intelligence, drug discovery, small molecule therapeutics, GEMS platform, oncology, immunology, strategic collaboration

Radiance Biopharma Secures $1.2 Billion Deal for Novel ROR1-Targeted Antibody-Drug Conjugate from CSPC

9 months ago talkbio0Tagged Antibody-Drug Conjugates, biopharmaceutical partnership, Dosage Forms, GZMH gene, Neoplasms, Radiance Biopharma, ROR1 protein, human

Radiance Biopharma, CSPC Pharmaceutical, ROR1, antibody-drug conjugate (ADC), oncology, licensing deal, biopharmaceutical partnership

AbbVie and Xilio Therapeutics Forge $2.1 Billion Partnership for Novel Tumor-Activated Immunotherapies

9 months ago talkbio0Tagged AbbVie, Collaboration, Drug Development, engagers, Immunotherapy, Neoplasms, T-Lymphocyte, tumor-activated

AbbVie, Xilio Therapeutics, immunotherapy, tumor-activated, T cell engagers, collaboration, oncology, drug development

AbbVie and Xilio Therapeutics Collaborate on $2.1B Deal for Novel Tumor-Activated Immunotherapies

9 months ago talkbio0Tagged AbbVie, biobucks, Collaboration, engagers, Neoplasms, T-Lymphocyte, tumor-activated

AbbVie, Xilio Therapeutics, T-cell engagers, tumor-activated immunotherapies, oncology, collaboration, biobucks deal

Merck KGaA in Advanced Talks to Acquire SpringWorks Therapeutics, Bolstering Oncology Portfolio

9 months ago talkbio0Tagged Acquisition, Drug Industry, Gomekli, Merck KGaA, Neoplasms, Ogsiveo, SpringWorks

Merck KGaA, SpringWorks Therapeutics, acquisition, oncology, rare diseases, Ogsiveo, Gomekli, pharmaceutical industry